Chemistry:Centhaquine

From HandWiki

Centhaquine (brand name Lyfaquin) is a cardiovascular drug.[1] In India, it is approved for the treatment of hypovolemic shock.[2]

Centhaquine is a vasopressor that activates α2A- and α2B-adrenoreceptors.[3] It increases venous return and improves tissue perfusion.

References

  1. ↑ "Resuscitative Effect of Centhaquine (Lyfaquin®) in Hypovolemic Shock Patients: A Randomized, Multicentric, Controlled Trial". Advances in Therapy 38 (6): 3223–3265. June 2021. doi:10.1007/s12325-021-01760-4. PMID 33970455. 
  2. ↑ "Marketing authorization received for Lyfaquin (centhaquine) to treat patients with hypovolemic shock from Indian regulatory agency" (Press release). May 14, 2020. Archived from the original on August 9, 2022. Retrieved April 25, 2024.
  3. ↑ "Effect of Centhaquine on the Coagulation Cascade in Normal State and Uncontrolled Hemorrhage: A Multiphase Study Combining Ex Vivo and In Vivo Experiments in Different Species". International Journal of Molecular Sciences 25 (6): 3494. March 2024. doi:10.3390/ijms25063494. PMID 38542464. 



Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:Centhaquine&oldid=4035469"